Skip to main content
559 Results
 
msf-placeholder
HIV/AIDS

This HIV-positive girl is lucky. 99% of Mozambican children get no treatment

This series of articles and audio/video files was researched and written by Guardian newspaper journalists and was a feature series running in the UK publication and website throughout the Christmas season. Click logo to access the full series on the Guardian website
Latest estimates from the Mozambique government show 1.5 million Mozambicans with HIV, with only 15,000 on ARVs as the government attempts to build up a national programme of treatment. It is a race against time
Photo Story - 30 Nov 2005
 
msf-placeholder
World AIDS Day

Children under two and AIDS

Across the globe last year, 700,000 children were newly infected with HIV – half a million of them live in Africa, compared to only 250 in Europe and North America. But there are no affordable AIDS tests that work in babies or medicines that kids can take easily. Project Update - 28 Nov 2005
 
msf-placeholder
Ethiopia

Kala azar complicates HIV/AIDS treatment in Humera

The MSF project in Humera is the only programme in Ethiopia, and one of very few in the world, which is treating people co-infected with kala azar and HIV. As such, it is breaking new ground in terms of developing the best medical approach for tackling the problem. Project Update - 28 Oct 2005
 
msf-placeholder
HIV/AIDS

MSF hands over Ukraine HIV/Aids programme

After a presence of six years in the Ukraine, the international medical aid organization Médecins Sans Frontières (MSF) is now handing over its HIV/Aids programme to the Ukraine Ministry of Health and national NGOs as LifePlus, Alternativa, UNITAS and Time to Live. Press Release - 27 Oct 2005
 
msf-placeholder
Ukraine

After six years, MSF hands over its HIV/Aids programme

Diagnosed with HIV that mostly leads to AIDS: for many still a dead sentence. Unacceptable! Especially since treatment is possible, enabling the patient to continue a valuable life in dignity. This is the reason why MSF started working in Ukraine. Project Update - 26 Oct 2005
 
msf-placeholder
Brazil

Action needed to tackle the second wave of the AIDS drug pricing crisis

MSF calls on governments to use all means at their disposal to decrease the prices of life-extending treatments for the poor. Project Update - 26 Jul 2005
 
msf-placeholder
HIV/AIDS

Prices of AIDS medicines in developing countries continue to be a concern

According to an MSF report, the current pricing system based on companies giving voluntary discounts to developing countries is not sufficient to guarantee affordability of medicines, now or in the future. The problems with this mechanism, known as differential pricing, fall into three broad categories. First, some single-source drugs are simply very expensive. Press Release - 28 Jun 2005
 
msf-placeholder
Tuberculosis

Global appeal for new treatments for neglected diseases is launched

Médecins Sans Frontières, other non-governmental organisations, scientists and a number of Nobel laureates around the world today joined the Drugs for Neglected Diseases Initiative in a global appeal to focus research on developing new drugs, diagnostic tests and vaccines for diseases of the poor. Press Release - 8 Jun 2005
 
msf-placeholder
HIV/AIDS

STI crisis in the West: Fuelling AIDS in Côte d’Ivoire

The civil war and subsequent collapse of the healthcare system have provoked a medical crisis in parts of Ivory Coast. Responding over the past two years to high levels of malaria, malnutrition and other diseases, MSF teams in the West of the country have encountered an alarmingly high number of sexually transmitted infections ("STIs"). Report - 27 Apr 2005
 
msf-placeholder
India

The future of generic medicines made in India

Prognosis: Short-term relief, long-term pain. The long-term impact of the Indian Patent Act is bad news for those relying on affordable new medicines - in MSF's own HIV/AIDS projects, for instance, approximately 70% of all patients currently take generic ARV medicines made in India. Worldwide, an estimated 350,000 people on ARV treatment depend on Indian generic production - that's half of all those on ARVs in developing countries. Project Update - 21 Apr 2005
Cholera intervention in South Kivu
Médecins Sans Frontières (MSF)

Independent medical humanitarian assistance

We provide medical assistance to people affected by conflict, epidemics, disasters, or exclusion from healthcare. Our teams are made up of tens of thousands of health professionals, logistic and administrative staff - most of them hired locally. Our actions are guided by medical ethics and the principles of independence and impartiality. We are a non-profit, self-governed, member-based organisation.

Learn more